Compare CLAR & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLAR | ACOG |
|---|---|---|
| Founded | 1957 | 2000 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.8M | 129.4M |
| IPO Year | N/A | N/A |
| Metric | CLAR | ACOG |
|---|---|---|
| Price | $3.61 | $5.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $5.33 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 109.8K | 65.6K |
| Earning Date | 03-05-2026 | 11-13-2025 |
| Dividend Yield | ★ 2.77% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $256,432,000.00 | $7,427,199.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.85 | $132.35 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.02 | $3.75 |
| 52 Week High | $5.08 | $11.54 |
| Indicator | CLAR | ACOG |
|---|---|---|
| Relative Strength Index (RSI) | 53.75 | 46.67 |
| Support Level | $3.50 | $5.20 |
| Resistance Level | $3.79 | $6.04 |
| Average True Range (ATR) | 0.15 | 0.46 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 52.00 | 41.87 |
Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.